rExenatide-4

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for rExenatide-4, covering 2011-04-26 to 2017-08-03. Get the full timeline:

Most recent: Clinical Trial Update: The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus [Phase 3]